ArticleThe AAPS journal2019

Model-Informed Drug Development Approach Supporting Approval of Adalimumab (HUMIRA) in Adolescent Patients with Hidradenitis Suppurativa: a Regulatory Perspective.

Youwei Bi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.